Emcure Pharmaceuticals IPO GMP Today, Emcure Pharma IPO Grey Market Premium Updates | Emcure Pharma IPO, Latest target, Opening gain
Incorporated in 1981, Emcure Pharmaceuticals Limited, an Indian pharmaceutical company, develops, manufactures, and globally markets a wide range of pharmaceutical products across several major therapeutic areas.
The company has been ranked 13th in domestic sales among pharmaceutical companies in India for MAT September 2023 and 4th in market share in its covered markets for the same period. Additionally, it is the leading pharmaceutical company in gynaecology and HIV antiviral therapeutic areas for the MAT September 2023.
Emcure Pharmaceuticals has 13 manufacturing facilities in India. These facilities can produce various pharmaceutical and biopharmaceutical products, including pills, liquids, injectables, and complex ingredients such as chiral molecules, iron molecules, and cytotoxic substances.
In the six months ended September 30, 2023, and the Financial Year 2023, sales in India contributed 50.84% and 53.16% of the company’s total revenue, respectively. The company’s Domestic sales grew at a CAGR of 10.80% between September 2019 and September 2023, outperforming the Indian pharmaceutical market.
As of September 30, 2023, Emcure Pharma employed 552 scientists and operated five research facilities in India. They filed over 1,800 documents globally, including 204 in the EU and 133 in Canada. They had 201 granted patents, 33 pending patent applications, and submitted 102 drug master files.
Emcure Pharmaceuticals IPO Details:
| Issuer | Emcure Pharma IPO | |
| Issue Type | Book Built Issue IPO | |
| Issue Period | Issue Opens: 03 July 2024 | |
| Issue Closes: 05 July 2024 | ||
| Price Brand | ₹960 to ₹1008 per share | |
| Issue Size | ₹1952.03 Cr | |
| Face Value | ₹10 per share | |
| Market Lot | 14 Shares | |
| Retail (Max) | ₹197,568 | |
| QIB | 50% | |
| HNI | 15% | |
| Retail Individual Bidders | 35% | |
| Listing at | NSE & BSE | |
| ✔️ Apply With | ANGEL Free DEMAT Account | |
| Total Shares | 19,365,346 shares | |
| UPCOMING IPO 2024 | Best sites for stock market |
| Best Stock Trading Apps 2024 | Best book for stock market beginners |
Emcure Pharmaceuticals IPO GMP Rates day by day
Emcure Pharma IPO Market Lot:
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 14 | ₹14,112 |
| Retail (Max) | 14 | 196 | ₹197,568 |
| S-HNI (Min) | 15 | 510 | ₹211,680 |
| S-HNI (Max) | 70 | 980 | ₹987,840 |
| B-HNI (Min) | 71 | 994 | ₹1,001,952 |
Emcure Pharma IPO Date, Allotment & Listing:
| Emcure Pharma IPO Opening Date: | JULY 03, 2024 |
| Emcure Pharma IPO Closing Date: | JULY 05, 2024 |
| Basis of Allotment: | JULY 08, 2024 |
| Initiation of Refunds: | JULY 09, 2024 |
| Credit to Demat Account: | JULY 09, 2024 |
| Listing Date: | JULY 10, 2024 |
Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)
Emcure Pharma Limited’s revenue increased by 1.91% and profit after tax (PAT) dropped by -20.03% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period Ended | 30 Sep 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 6,715.03 | 6,672.53 | 6,063.47 | 6,807.40 |
| Revenue | 3,235.56 | 6,031.72 | 5,918.86 | 5,067.35 |
| Profit After Tax | 286.80 | 561.85 | 702.56 | 418.59 |
| Net Worth | 2,750.97 | 2,501.13 | 1,987.55 | 2,273.02 |
| Reserves and Surplus | 2,543.85 | 2,293.77 | 1,791.03 | 2,016.15 |
| Total Borrowing | 2,012.86 | 2,202.42 | 2,102.19 | 2,332.87 |
| Amount in ₹ Crore | ||||
Key Performance Indicator
The market capitalization of Emcure Pharma IPO is Rs 19029.89 Cr.
| KPI | Values |
|---|---|
| ROE | 16.90% |
| ROCE | 19.37% |
| Debt/Equity | 0.67 |
| RoNW | 16.87% |
| P/BV | 6.18 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 29.17 | 27.95 |
| P/E (x) | 34.55 | 36.07 |
Objects of the Issue (Emcure Pharma IPO Objectives)
- Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by the company; and
- General corporate purposes
Emcure Pharmaceuticals IPO ALLOTMENT STATUS
How to Apply for Emcure Pharmaceuticals IPO?
If you’re a new investor Open a DEMAT Account for free with Angel One and build wealth with the best stock choices. Join a 1 million+ family of happy customers.
How to Apply Emcure Pharmaceuticals IPO through Zerodha?
Log in to the Console in the Zerodha Website or Application. Go to Portfolio and Click on IPO. You will see the IPO Name “Emcure Pharma”. Click on the Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open a Demat Account with Zerodha.
How to Apply Emcure Pharma IPO through Upstox?
Log in to the Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Emcure Pharma”. Click on the Bid Button. Confirm your application. Now go to your UPI App on Net Banking or BHIM App to Approve – the mandate. Open a Demat Account with Upstox.
In case you have not been allotted or for any partial allotment of IPO shares, the blocked amount, if any, will be unblocked/released on or before the UPI mandate expiry date. Please reach out to your bank in case funds are not unblocked/released after the mandate expiry date.
PARENT COMPANY FOR SHAREHOLDER QUOTA
IPO ALLOTMENT TIPS & TRICKS
Frequently Asked Questions
Emcure Pharmaceuticals IPO is a main-board initial public offering of 19,365,346 Equity shares of the face value of ₹10 aggregating up to ₹1952.03 Crores. The issue price of the IPO is ₹960 to ₹1008 Per Equity Share. The minimum order quantity is 14 Shares per application and the offer type is Book Built Issue. The IPO opens on July 03, 2024 and closes on July 05, 2024. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Emcure Pharma IPO opens on July 03, 2024 and closes on July 05, 2024.
You can apply in Emcure Pharma IPO online using either UPI or ASBA as payment method. Kotak Mahindra Capital Company Limited, Axis Capital Limited, J.P. Morgan India Private Limited and Jefferies India Private Limited are the book running lead managers of the Emcure Pharma IPO, while Link Intime India Private Ltd is the registrar for the issue.
The finalization of Basis of Allotment for Emcure Pharma IPO will be done on July 08, 2024, and the allotted shares will be credited to your demat account by July 09, 2024. Check the Emcure Pharma IPO allotment status.
The Emcure Pharma IPO listing date is not yet announced. The tentative date of Emcure Pharma IPO listing is July 10, 2024.
Emcure Pharma IPO lot size is 14 Shares and the minimum order quantity is 1 Shares.